Request for Covid-19 Impact Assessment of this Report

Materials and Chemicals

Alpha Lipoic Acid Market by Product Type (R Alpha Lipoic Acid and S Alpha Lipoic Acid) and Application (Dietary Supplements, Cosmetics, Pharmaceuticals, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

  • ALL4676835
  • 260 Pages
  • September 2021
  • Materials and Chemicals
Download Sample    Get Discount   
 
The global alpha lipoic acid market was valued at $784.5 million in 2020, and is projected to reach $1,442.4 million by 2030, growing at a CAGR of 6.3% from 2021 to 2030.

Alpha lipoic acid is a naturally occurring organic compound with antioxidant properties used to break down carbohydrates and transform it into energy. It if found naturally in the body or can be prepared synthetically by chemical synthesis of thioctic acid with R(+) alpha-methylbenzylamine.

The growth of the global alpha lipoic acid market is driven by robust dietary supplements and increasing demand for anti-aging creams. Aging is brought by a cycle of biochemical processes that degenerates the body over time. Anti-aging is the process of retarding or limiting these changes by using different products and services. Nowadays, a good physical personality has become a necessity among individuals, which in turn has increased the awareness for using anti-aging products among both young and older populations. For instance, according to a report published by Statista, the global anti-aging market was valued at around $58.5 billion in 2020 and is expected to reach $88.3 billion by 2026. Alpha-lipoic acid being rich in antioxidants protects the skin from ultraviolet light, cigarette smoke, air pollution, and others. Moreover, it is also proven for use as sun protection, anti-wrinkle, dark sports treatment, and anti-aging products.

However, side effects associated with use of lipoic acid such as headaches, nausea, heartburn, and vomiting, which is expected to hamper the market growth. The regular consumption of alpha-lipoic acid may cause several side effects. For example, the regular consumption of alpha-lipoic acid in adults may cause headaches, nausea, heartburn, and vomiting. Moreover, using alpha-lipoic acid together with other health supplements may lower blood sugar levels and cause hypoglycemia. Furthermore, the skin applications of alpha-lipoic acid may cause a rash in some people. These factors together may hamper the growth of the alpha-lipoic acid market during the forecast period.

The rapid change in lifestyle, ethnicity, energy-dense diet, physical inactivity, obesity, and others is the main contributor to an increasing prevalence of diabetes. For instance, according to a report published by the World Health Organization (WHO), the number of people with diabetes rose from 108 million in 1980 to around 422 million in 2014. Several researches have found alpha-lipoic acid one of the best health supplements for people with type-2 diabetes. Moreover, it can improve insulin resistance and nerve damage caused by diabetes treatment. It reduces symptoms such as tingling, pain, and pricking in the legs and feet of diabetic patients. In addition, it protects the retina from being damaged due to high blood sugar levels. These factors together are anticipated to increase the sales of alpha-lipoic acid may offer remunerative opportunities for the alpha lipoic acid market in future.

The alpha lipoic acid market is segmented on the basis of product type, application, and region. On the basis of product type, the market is categorized into product type, the market is divided into R alpha lipoic acid and S alpha lipoic acid. By application, it is classified into dietary supplements, cosmetics, pharmaceuticals, and others. Region-wise, the market is studied across North America, Europe, Asia-Pacific, and LAMEA.

The global alpha lipoic acid market profiles leading players that include AlzChem Group AG, GeroNova Research Inc., Haihang Industry, HiMedia Laboratories, NOW Foods, Olon S.p.A, Rexall Sundown Inc., Source Naturals Inc., Suzhou Fushilai Pharmaceutical Co. Ltd., and Wellona Pharma.

The global alpha lipoic acid market report provides in-depth competitive analysis as well as profiles of these major players.

1.1. Key benefits for stakeholders

• Porter’s five forces analysis helps analyze the potential of buyers & suppliers and the competitive scenario of the industry for strategy building.

• It outlines the current trends and future estimations of the market from 2020 to 2030 to understand the prevailing opportunities and potential investment pockets.

• The major countries in the region have been mapped according to their individual revenue contribution to the regional market.

• The key drivers, restraints, and opportunities and their detailed impact analysis are explained in the study.

• The profiles of key players and their key strategic developments are enlisted in the report.

1.2. Key market segments

• By Product Type

• R Alpha Lipoic Acid

• S Alpha Lipoic Acid

• By Application

• Dietary Supplements

• Cosmetics

• Pharmaceuticals

• Others

• By Region

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o UK

o France

o Italy

o Spain

o Rest of Europe

• Asia-Pacific

o China

o Japan

o India

o South Korea

o Australia

o Rest of Asia-Pacific

• LAMEA

o Brazil

o Saudi Arabia

o South Africa

o Rest of LAMEA

Key players in the global alpha lipoic acid market are:

1. AlzChem Group AG

2. GeroNova Research Inc.

3. Haihang Industry

4. HiMedia Laboratories

5. NOW Foods

6. Olon S.p.A

7. Rexall Sundown Inc.

8. Source Naturals Inc.

9. Suzhou Fushilai Pharmaceutical Co. Ltd.

10. Wellona Pharma

CHAPTER 1:INTRODUCTION

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.5.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.3.Porter’s five forces analysis

3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Robust dietary supplements demand

3.4.1.2.Increasing demand for anti-aging creams

3.4.2.Restraint

3.4.2.1.Side-effects associated with the use of alpha-lipoic acid

3.4.3.Opportunity

3.4.3.1.Increasing utilization for nerve pain treatment in people with diabetes

3.5.Value chain analysis

3.6.Pricing analysis

3.7.Impact of key regulations on the global alpha lipoic acid market

3.8.Impact of COVID-19 on the global alpha lipoic acid market

3.9.Patent analysis, 2012-2021

CHAPTER 4:GLOBAL ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE

4.1.Overview

4.1.1.Market size and forecast, by product type

4.2.R alpha lipoic acid

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market share analysis, by country

4.3.S alpha lipoic acid

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast, by region

4.3.3.Market share analysis, by country

CHAPTER 5:ALPHA LIPOIC ACID MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Dietary supplements

5.2.1.Key market trends, growth factors, and opportunities

5.2.2.Market size and forecast, by region

5.2.3.Market share analysis, by country

5.3.Cosmetics

5.3.1.Key market trends, growth factors, and opportunities

5.3.2.Market size and forecast, by region

5.3.3.Market share analysis, by country

5.4.Pharmaceuticals

5.4.1.Key market trends, growth factors, and opportunities

5.4.2.Market size and forecast, by region

5.4.3.Market share analysis, by country

5.5.Others

5.5.1.Key market trends, growth factors, and opportunities

5.5.2.Market size and forecast, by region

5.5.3.Market share analysis, by country

CHAPTER 6:ALPHA LIPOIC ACID MARKET, BY REGION

6.1.Overview

6.1.1.Market size and forecast

6.2.North America

6.2.1.Key market trends, growth factors, and opportunities

6.2.2.Market size and forecast, by product type

6.2.3.Market size and forecast, by application

6.2.4.Market share analysis, by country

6.2.5.U.S.

6.2.5.1.Market size and forecast, by product type

6.2.5.2.Market size and forecast, by application

6.2.6.Canada

6.2.6.1.Market size and forecast, by product type

6.2.6.2.Market size and forecast, by application

6.2.7.Mexico

6.2.7.1.Market size and forecast, by product type

6.2.7.2.Market size and forecast, by application

6.3.Europe

6.3.1.Key market trends, growth factors, and opportunities

6.3.2.Market size and forecast, by product type

6.3.3.Market size and forecast, by application

6.3.4.Market size and forecast, by country

6.3.5.Germany

6.3.5.1.Market size and forecast, by product type

6.3.5.2.Market size and forecast, by application

6.3.6.UK

6.3.6.1.Market size and forecast, by product type

6.3.6.2.Market size and forecast, by application

6.3.7.France

6.3.7.1.Market size and forecast, by product type

6.3.7.2.Market size and forecast, by application

6.3.8.Italy

6.3.8.1.Market size and forecast, by product type

6.3.8.2.Market size and forecast, by application

6.3.9.Spain

6.3.9.1.Market size and forecast, by product type

6.3.9.2.Market size and forecast, by application

6.3.10.Rest of Europe

6.3.10.1.Market size and forecast, by product type

6.3.10.2.Market size and forecast, by application

6.4.Asia-Pacific

6.4.1.Key market trends, growth factors, and opportunities

6.4.2.Market size and forecast, by product type

6.4.3.Market size and forecast, by application

6.4.4.Market size and forecast, by country

6.4.5.China

6.4.5.1.Market size and forecast, by product type

6.4.5.2.Market size and forecast, by application

6.4.6.Japan

6.4.6.1.Market size and forecast, by product type

6.4.6.2.Market size and forecast, by application

6.4.7.India

6.4.7.1.Market size and forecast, by product type

6.4.7.2.Market size and forecast, by application

6.4.8.Australia

6.4.8.1.Market size and forecast, by product type

6.4.8.2.Market size and forecast, by application

6.4.9.South Korea

6.4.9.1.Market size and forecast, by product type

6.4.9.2.Market size and forecast, by application

6.4.10.Rest of Asia-Pacific

6.4.10.1.Market size and forecast, by product type

6.4.10.2.Market size and forecast, by application

6.5.LAMEA

6.5.1.Key market trends, growth factors, and opportunities

6.5.3.Market size and forecast, by product type

6.5.4.Market size and forecast, by application

6.5.5.Market size and forecast, by country

6.5.6.Brazil

6.5.6.1.Market size and forecast, by product type

6.5.6.2.Market size and forecast, by application

6.5.7.Saudi Arabia

6.5.7.1.Market size and forecast, by product type

6.5.7.2.Market size and forecast, by application

6.5.8.South Africa

6.5.8.1.Market size and forecast, by product type

6.5.8.2.Market size and forecast, by application

6.5.9.Rest of LAMEA

6.5.9.1.Market size and forecast, by product type

6.5.9.2.Market size and forecast, by application

CHAPTER 7:COMPETITIVE LANDSCAPE

7.1.INTRODUCTION

7.1.1.MARKET PLAYER POSITIONING, 2020

7.2.PRODUCT MAPPING OF TOP 10 PLAYER

7.3.COMPETITIVE DASHBOARD

7.4.COMPETITIVE HEATMAP

CHAPTER 8:COMPANY PROFILES:

8.1.AlzChem Group AG

8.1.1.Company overview

8.1.2.Company snapshot

8.1.3.Operating business segments

8.1.4.Product portfolio

8.1.5.Business performance

8.2.GeroNova Research, Inc.

8.2.1.Company overview

8.2.2.Company snapshot

8.2.3.Product portfolio

8.3.Haihang Industry

8.3.1.Company overview

8.3.2.Company snapshot

8.3.3.Product portfolio

8.4.HiMedia Laboratories

8.4.1.Company overview

8.4.2.Company snapshot

8.4.3.Product portfolio

8.5.NOW Foods

8.5.1.Company overview

8.5.2.Company snapshot

8.5.3.Operating business segments

8.5.4.Product portfolio

8.6.Olon S.p.A.

8.6.1.Company overview

8.6.2.Company snapshot

8.6.3.Product portfolio

8.7.Rexall Sundown, Inc.

8.7.1.Company overview

8.7.2.Company snapshot

8.7.3.Operating business segments

8.7.4.Product portfolio

8.8.Source Naturals, Inc.

8.8.1.Company overview

8.8.2.Company snapshot

8.8.3.Product portfolio

8.9.SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD.

8.9.1.Company overview

8.9.2.Company snapshot

8.9.3.Product portfolio

8.10.Wellona Pharma

8.10.1.Company overview

8.10.2.Company snapshot

8.10.3.Product portfolio

LIST OF TABLES

TABLE 01.GLOBAL ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)

TABLE 02.GLOBAL ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020-2030 (TON)

TABLE 03.ALPHA LIPOIC ACID MARKET FOR R ALPHA LIPOIC ACID, BY REGION, 2020–2030 ($MILLION)

TABLE 04.ALPHA LIPOIC ACID MARKET FOR R ALPHA LIPOIC ACID, BY REGION, 2020–2030 (TON)

TABLE 05.ALPHA LIPOIC ACID MARKET FOR S ALPHA LIPOIC ACID, BY REGION, 2020–2030 ($MILLION)

TABLE 06.ALPHA LIPOIC ACID MARKET FOR S ALPHA LIPOIC ACID, BY REGION, 2020–2030 (TON)

TABLE 07.GLOBAL ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020-2030 ($MILLION)

TABLE 08.GLOBAL ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020-2030 (TON)

TABLE 09.ALPHA LIPOIC ACID MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2020–2030 ($MILLION)

TABLE 10.ALPHA LIPOIC ACID MARKET FOR DIETARY SUPPLEMENTS, BY REGION, 2020–2030 (TON)

TABLE 11.ALPHA LIPOIC ACID MARKET FOR COSMETICS, BY REGION, 2020–2030 ($MILLION)

TABLE 12.ALPHA LIPOIC ACID MARKET FOR COSMETICS, BY REGION, 2020–2030 (TON)

TABLE 13.ALPHA LIPOIC ACID MARKET FOR PHARMACEUTICALS, BY REGION, 2020–2030 ($MILLION)

TABLE 14.ALPHA LIPOIC ACID MARKET FOR PHARMACEUTICALS, BY REGION, 2020–2030 (TON)

TABLE 15.ALPHA LIPOIC ACID MARKET FOR OTHERS, BY REGION, 2020–2030 ($MILLION)

TABLE 16.ALPHA LIPOIC ACID MARKET FOR OTHERS, BY REGION, 2020–2030 (TON)

TABLE 17.ALPHA LIPOIC ACID MARKET, BY REGION, 2020–2030 ($MILLION)

TABLE 18.ALPHA LIPOIC ACID MARKET, BY REGION, 2020–2030 (TON)

TABLE 19.NORTH AMERICA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 20.NORTH AMERICA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 21.NORTH AMERICA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 22.NORTH AMERICA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 23.NORTH AMERICA ALPHA LIPOIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 24.NORTH AMERICA ALPHA LIPOIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)

TABLE 25.U.S. ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 26.U.S. ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 27.U.S. ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 28.U.S. ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 29.CANADA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 30.CANADA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 31.CANADA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 32.CANADA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 33.MEXICO ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 34.MEXICO ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 35.MEXICO ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 36.MEXICO ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 37.EUROPE ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 38.EUROPE ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 39.EUROPE ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 40.EUROPE ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 41.EUROPE ALPHA LIPOIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 42.EUROPE ALPHA LIPOIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)

TABLE 43.GERMANY ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 44.GERMANY ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 45.GERMANY ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 46.GERMANY ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 47.U.K. ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 48.U.K. ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 49.U.K. ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 50.U.K. ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 51.FRANCE ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 52.FRANCE ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 53.FRANCE ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 54.FRANCE ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 55.ITALY ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 56.ITALY ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 57.ITALY ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 58.ITALY ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 59.SPAIN ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 60.SPAIN ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 61.SPAIN ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 62.SPAIN ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 63.REST OF EUROPE ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 64.REST OF EUROPE ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 65.REST OF EUROPE ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 66.REST OF EUROPE ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 67.ASIA-PACIFIC ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 68.ASIA-PACIFIC ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 69.ASIA-PACIFIC ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 70.ASIA-PACIFIC ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 71.ASIA-PACIFIC ALPHA LIPOIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 72.ASIA-PACIFIC ALPHA LIPOIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)

TABLE 73.CHINA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 74.CHINA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 75.CHINA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 76.CHINA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 77.JAPAN ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 78.JAPAN ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 79.JAPAN ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 80.JAPAN ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 81.INDIA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 82.INDIA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 83.INDIA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 84.INDIA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 85.AUSTRALIA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 86.AUSTRALIA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 87.AUSTRALIA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 88.AUSTRALIA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 89.SOUTH KOREA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 90.SOUTH KOREA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 91.SOUTH KOREA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 92.SOUTH KOREA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 93.REST OF ASIA-PACIFIC ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 94.REST OF ASIA-PACIFIC ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 95.REST OF ASIA-PACIFIC ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 96.REST OF ASIA-PACIFIC ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 97.LAMEA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 98.LAMEA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 99.LAMEA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 100.LAMEA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 101.LAMEA ALPHA LIPOIC ACID MARKET, BY COUNTRY, 2020–2030 ($MILLION)

TABLE 102.LAMEA ALPHA LIPOIC ACID MARKET, BY COUNTRY, 2020–2030 (TON)

TABLE 103.BRAZIL ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 104.BRAZIL ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 105.BRAZIL ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 106.BRAZIL ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 107.SAUDI ARABIA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 108.SAUDI ARABIA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 109.SAUDI ARABIA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 110.SAUDI ARABIA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 111.SOUTH AFRICA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 112.SOUTH AFRICA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 113.SOUTH AFRICA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 114.SOUTH AFRICA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 115.REST OF LAMEA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 ($MILLION)

TABLE 116.REST OF LAMEA ALPHA LIPOIC ACID MARKET, BY PRODUCT TYPE, 2020–2030 (TON)

TABLE 117.REST OF LAMEA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 ($MILLION)

TABLE 118.REST OF LAMEA ALPHA LIPOIC ACID MARKET, BY APPLICATION, 2020–2030 (TON)

TABLE 119.ALZCHEM GROUP AG: COMPANY SNAPSHOT

TABLE 120.ALZCHEM GROUP AG: OPERATING SEGMENTS

TABLE 121.ALZCHEM GROUP AG: PRODUCT PORTFOLIO

TABLE 122.OVERALL FINANCIAL STATUS ($MILLION)

TABLE 123.GERONOVA RESEARCH, INC.: COMPANY SNAPSHOT

TABLE 124.GERONOVA RESEARCH, INC.: PRODUCT PORTFOLIO

TABLE 125.HAIHANG INDUSTRY: COMPANY SNAPSHOT

TABLE 126.HAIHANG INDUSTRY: PRODUCT PORTFOLIO

TABLE 127.HIMEDIA LABORATORIES: COMPANY SNAPSHOT

TABLE 128.HIMEDIA LABORATORIES: PRODUCT PORTFOLIO

TABLE 129.NOW FOOD: COMPANY SNAPSHOT

TABLE 130.NOW FOOD: OPERATING SEGMENTS

TABLE 131.NOW FOOD: PRODUCT PORTFOLIO

TABLE 132.OLON S.P.A: COMPANY SNAPSHOT

TABLE 133.OLON S.P.A: PRODUCT PORTFOLIO

TABLE 134.REXALL SUNDOWN, INC.: COMPANY SNAPSHOT

TABLE 135.REXALL SUNDOWN, INC.: OPERATING SEGMENTS

TABLE 136.REXALL SUNDOWN, INC.: PRODUCT PORTFOLIO

TABLE 137.SOURCE NATURALS, INC.: COMPANY SNAPSHOT

TABLE 138.SOURCE NATURALS, INC.: PRODUCT PORTFOLIO

TABLE 139.SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD.: COMPANY SNAPSHOT

TABLE 140.SUZHOU FUSHILAI PHARMACEUTICAL CO., LTD.: PRODUCT PORTFOLIO

TABLE 141.WELLONA PHARMA: COMPANY SNAPSHOT

TABLE 142.WELLONA PHARMA: PRODUCT PORTFOLIO

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Global Photonic Crystals Market (Construction Strategies, Geography , Applications) - Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2013 - 2020

Photonic Crystals are attractive optical materials for controlling and manipulating the flow of light. The global market for components and modules using Photonic Crystals indicates a CAGR of 33.1% and is estimated to reach $20.4 billion in 2017.

  • Publish Date: February 8, 2017
  • $5370
Molded Plastics Market by Product (Polyvinyl Chloride, Polypropylene, Polystyrene, Low Density Polyethylene, High Density Polyethylene, Polyethylene Terephthalate, and Engineering Plastics), Technology (Injection Molding, Blow Molding, Extrusion, and Others), and Application (Building & Construction, Electrical & Electronics, Automotive and Packaging) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Global molded plastics market was valued at $529,845 million in 2016, and is expected to garner $690,158 million by 2023, registering a CAGR of 3.9% from 2017 to 2023. Molded plastics are synthetically produced non-metallic compounds, which can be molded ...

  • Publish Date: July 4, 2017
  • $5370